Targeting tumour-supportive cellular machineries in anticancer drug development.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2014 AND VI 13 AND IP 3
Results: 26
1
2
Trial watch: global migration of clinical trials.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Built-to-buy start-ups begin to bloom.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 161, doi. 10.1038/nrd4258
- By:
- Publication type:
- Article
4
Neurological disorders: Presynaptic glycine receptors become a startling target.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 177, doi. 10.1038/nrd4265
- By:
- Publication type:
- Article
5
Anticancer drugs: Double boost for doxorubicin therapy.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4268
- By:
- Publication type:
- Article
6
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 157, doi. 10.1038/nrd4256
- Publication type:
- Article
7
Targeting tumour-supportive cellular machineries in anticancer drug development.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 179, doi. 10.1038/nrd4201
- By:
- Publication type:
- Article
8
Trail watch: Global migration of clinical trials.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 166, doi. 10.1038/nrd4260
- By:
- Publication type:
- Article
9
John Reed.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 170, doi. 10.1038/nrd4262
- Publication type:
- Article
10
Kinase inhibitors overachieve in CLL.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 162, doi. 10.1038/nrd4259
- By:
- Publication type:
- Article
11
Anticancer drugs: A clearer pathway view.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 176, doi. 10.1038/nrd4267
- By:
- Publication type:
- Article
12
Autoimmune disease: Antidiabetic mechanisms uncovered.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4271
- By:
- Publication type:
- Article
13
Antibody engineering: Fine-tuning antibody-drug conjugates.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4266
- By:
- Publication type:
- Article
14
FDA dissects 12 years of complete response letters.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 165, doi. 10.1038/nrd4272
- Publication type:
- Article
15
Epigenetics: Banishing bad memories.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4269
- By:
- Publication type:
- Article
16
Inflammatory disorders: Monocytes derailed by microparticles.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 175, doi. 10.1038/nrd4263
- By:
- Publication type:
- Article
17
Policies to aid the adoption of personalized medicine.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 159, doi. 10.1038/nrd4257
- By:
- Publication type:
- Article
18
Recent patents related to p53.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 169, doi. 10.1038/nrd4277
- Publication type:
- Article
19
The BACE race is on.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 165, doi. 10.1038/nrd4274
- Publication type:
- Article
20
REV-ERB and ROR nuclear receptors as drug targets.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 197, doi. 10.1038/nrd4100
- By:
- Publication type:
- Article
21
Drugging the p53 pathway: understanding the route to clinical efficacy.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 217, doi. 10.1038/nrd4236
- By:
- Publication type:
- Article
22
Systemic lupus erythematosus and lupus nephritis.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 173, doi. 10.1038/nrd4227
- By:
- Publication type:
- Article
23
Vascular disease: a new way to starve vascular endothelial cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
24
Target identification: Targeting neuronal loss in Gaucher's disease.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4270
- By:
- Publication type:
- Article
25
An antibiotic comeback?
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 165, doi. 10.1038/nrd4273
- Publication type:
- Article
26
Patentee bears burden of proof when licence agreements are questioned.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 168, doi. 10.1038/nrd4276
- By:
- Publication type:
- Article